Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1982-03-30
1989-02-07
Hazel, Blondel
Chemistry: molecular biology and microbiology
Spore forming or isolating process
424 858, 530387, 530388, 436548, C12N 500, G01N 3353, C07K 1502
Patent
active
048031674
ABSTRACT:
The present invention discloses a hybridoma culture and high affinity monoclonal antidigoxin antibodies produced by somatic cell fusion. The antibodies are useful for therapeutic as well as for diagnostic purposes. They are also useful in a model system for the study of structure-function relationships in antigen-antibody specific reactions.
REFERENCES:
Margolies, M. et al., Monoclonal Antibodies and T Cell Hybrd, pp. 367-374, Elseveer/North Holland Biomedical Press, Amsterdam, 1981.
Zurawski, Jr. et al., J. Immunology, vol. 121, No. 1, 1978.
Mudgett-Hunter et al., Abstracts of Fourth International Congress of Immunology, Paris, No. 19.2.14, 1980.
Novolny et al., FASEB Abstract, 40:1098, 1981.
Bany et al., Scand. J. Clin. Lab. Invest., vol. 41, pp. 75-78 (1981).
Mudgett-Hunter et al., Fed. Proc., vol. 39, No. 3, p. 928 (1980).
Sevier et al., Clin. Chem., vol. 27, No. 11, pp. 1797-1806 (1981).
Haber Edgar
Margolies Michael
Mudgett-Hunter Meredith
Hazel Blondel
The General Hospital Corporation
LandOfFree
Monoclonal antidigoxtin antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antidigoxtin antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antidigoxtin antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1084687